GemAOD
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GemAOD, covering 2013-08-22 to 2013-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma [Phase 2]